Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating income | -$2.57M | -$10.5M | -$15.4M | -$25.1M | -$29.9M | -$39.7M |
| Net income | $6.64M | -$10.5M | -$14.8M | -$24.0M | -$26.7M | -$36.1M |
| EPS (diluted) | -$3.96 | -$3.69 | -$0.93 | -$1.50 | -$0.46 | -$0.38 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$1.03M | -$8.80M | -$13.5M | -$21.0M | -$14.6M | -$26.4M |
| Capital expenditures | — | $0.00 | $36.8K | $0.00 | $7.32K | $33.9K |
| Free cash flow | — | -$8.80M | -$13.6M | -$21.0M | -$14.6M | -$26.4M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $291K | $49.6M | $35.5M | $14.4M | $94.4M | $66.0M |
| Total assets | $467K | $51.3M | $38.0M | $16.1M | $98.1M | $68.5M |
| Total liabilities | $9.62M | $3.03M | $3.21M | $4.19M | $2.86M | $8.02M |
| Shareholders' equity | -$16.9M | $48.3M | $34.8M | $11.9M | $95.3M | $60.5M |
| Retained earnings | -$18.8M | -$29.3M | -$44.1M | -$68.1M | -$94.8M | -$131M |
| Shares (wtd avg diluted) | 2.05M | 2.83M | 16.0M | 16.0M | 58.4M | 95.2M |
Every figure is extracted from Context Therapeutics Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.